Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family

Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family

US Patent 5679683 · Granted Oct 21, 1997

Estimated economic value: $69,919,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptide compositions and methods of use2025
Peptide compositions and methods of use2023
Tricyclic heterocyclic derivatives and uses thereof2021
Tricyclic heterocyclic derivatives and uses thereof2021
Glucosylceramide synthase inhibitors for the treatment of diseases2021
Compounds and synthetic methods for the preparation of retinoid X receptor-speci2021
Histone deacetylase inhibitors2020
Peptide compositions and methods of use2020
Pyrimidinyl tyrosine kinase inhibitors2020
Compounds and synthetic methods for the preparation of retinoid X receptor-speci2020
1-(Chloromethyl)-2,3-dihydro-1H-benzo[e]indole dimer antibody-drug conjugate com2020
1-(Chloromethyl)-2,3-dihydro-1H-benzo[e]indole dimer antibody-drug conjugate com2020